|
Dr. Weissinger is President and CEO of Weissinger Solutions, Inc., a consulting and contract service group providing strategic guidance for global regulatory challenges applicable to pharmaceutical, medical device, and biological products. Dr. Weissinger has been in the regulatory field for over 30 years, with about ten years each in academia, at FDA, and in industry. While in industry, in addition to consulting, Dr. Weissinger was Vice President of Regulatory Affairs and of Quality Assurance at Applied Immune Sciences and PRP Gencell, and a Director of Regulatory Affairs and Preclinical and Clinical Compliance at Glaxo Research Institute. While at FDA, Dr. Weissinger was pivotally involved in ICH while serving as the head of Pharmacology/Toxicology at CDER and at CBER to develop policy that impacted on national and international safety standards. At FDA she was initially a reviewer of human food safety at CVM, and detailed as acting Deputy Director of OST, CDRH./www.moleculartherapeutics.com/team.htm | 